ÂÜÀòÂÒÂ×

Jeff Mitchell has a diverse work experience in the healthcare industry. Jeff started their career in 2003 as a Professional Research Assistant at the University of Colorado. From 2007 to 2012, they worked as an Associate Scientist at Merrimack Pharmaceuticals, where they contributed to early-stage drug discovery projects.

In 2012, Jeff had various roles as an MBA Intern at MassBio, a Consultant at The Forsyth Institute, and a Market Consultant at Boston Biomedical Consultants, specializing in molecular diagnostics. Jeff then worked as an Innovation Consultant and Project Leader at Partners HealthCare, where they screened active inventions and supported the Partners Innovation Fund.

In 2014, Jeff joined Enzymatics as an Associate Product Manager and later moved to ArcherDX, where they served as an Associate Product Manager, responsible for advancing the adoption of Next-Generation Sequencing products for cancer diagnostics.

From 2016 to 2019, Jeff held multiple positions at Admera Health, starting as an Associate Product Manager and progressing to Director of Strategy and Marketing. Jeff then took on the role of Senior Director before becoming Interim CEO and ultimately Vice President of Corporate Affairs. During their tenure, they managed marketing teams, collaborated with leadership and key opinion leaders, and contributed to significant revenue growth.

Overall, Jeff Mitchell's work experience encompasses roles in product management, strategy, marketing, and leadership in the healthcare and biotech industry with a focus on precision medicine and molecular diagnostics.

Jeff Mitchell has a Bachelor of Science degree in Biochemistry from Colorado State University. Jeff then went on to pursue an MBA from the Questrom School of Business at Boston University, specializing in Health Sector Management and Finance. Additionally, they have completed coursework in the field of Structural Analysis of Biomolecules at the University of Colorado Denver Health Sciences Center.